October 29, 2026 · Capital & Resources, Innovators

Building Biotech on Alabama’s Gulf Coast: How Hatch Fairhope Is Helping Grow a Life Sciences Ecosystem

When people think about biotechnology innovation, they often picture major research hubs on the east and west coasts. Increasingly, however, new life sciences companies are emerging in a different place: South Alabama.

Across the Gulf Coast region, founders are developing advanced tissue-engineered models for drug discovery, bringing new orthopedic technologies to market and creating innovative solutions for medical device sterilization. While their technologies address different challenges, these companies share a common thread: they are helping demonstrate that Alabama’s life sciences sector is growing well beyond traditional industry centers.

One organization helping connect many of these innovators is Hatch Fairhope, a regional innovation hub that serves entrepreneurs across technology, life sciences and the creative economy. Through programs such as the Hatch Biotech Accelerator, powered by Bessel, founders gain access to mentorship, commercialization guidance, regulatory expertise and investor connections designed to help science-based companies grow in Alabama.

Hatch is part of a broader network of organizations working to strengthen Alabama’s entrepreneurial ecosystem, with support from initiatives such as Innovate Alabama’s Tax Credit Program, which allows individuals and businesses to support qualifying economic development organizations through tax credit eligible contributions. For Hatch, that support helps connect founders with the expertise, relationships, and opportunities they need to turn promising ideas into growing businesses.

For Hatch Executive Director Keith Glines, the opportunity is clear. “South Alabama has the research institutions, health care infrastructure and entrepreneurial talent to build a nationally recognized life sciences community. Hatch’s role is to connect those pieces and help founders turn great science into companies that can grow here.”

That vision is taking shape through companies such as VivoSphere, Endeavor Orthopaedics and Gulf Sterilization. Together, their stories illustrate both the diversity of innovation taking place across Alabama and the growing strength of the state’s entrepreneurial support network.

VivoSphere: Advancing Alabama Innovation on a Global Stage

Born from research at Auburn University, VivoSphere develops advanced 3D tissue-engineered models that more closely replicate how human cells respond to potential drug treatments. By providing researchers with more predictive data earlier in the development process, the technology has the potential to improve drug discovery while reducing cost and risk.

The company’s growth reflects the power of Alabama’s connected innovation ecosystem. VivoSphere previously received an Innovate Alabama SBIR/STTR Supplemental Grant, helping advance its technology and address commercialization challenges.

In May 2026, VivoSphere won the Life Sciences Track of the Alabama Launchpad competition and just one month later, the company announced a global launch, expanding access to research partners and customers across the United Kingdom and European Union.

VivoSphere has also participated in Hatch’s biotech programming, adding another connection point within the state’s growing life sciences community.

Endeavor Orthopaedics: Turning Ideas Into Impact

While some life sciences companies focus on innovative research technology, others focus on bringing practical medical solutions directly to the patient.

Endeavor Orthopaedics is developing innovative technologies for complex fractures, including its FDA-cleared Summit Patella Plating System. The company participated in Hatch’s inaugural biotech accelerator cohort in 2024, gaining support as it refined its commercialization strategy and prepared for growth.

Since completing the program, Endeavor has continued to build momentum. In August, the company announced completion of its 300th implant using the Summit system, marking a significant milestone in its path from startup to commercial-stage medical device company.

The company has also received support through an Innovate Alabama-backed SSBCI investment, demonstrating how Alabama entrepreneurs can leverage multiple pathways to access capital, mentorship and growth resources.

Its continued success highlights an important reality of startup development: meaningful ecosystem support extends beyond any single accelerator cohort, competition or funding opportunity.

Gulf Sterilization: Building Critical Infrastructure in Mobile

In Mobile, Gulf Sterilization is tackling a challenge that affects medical device manufacturers across the country.

Founded by Michelle Scott, the company provides contract sterilization services using chlorine dioxide gas technology. Its location near the Port of Mobile creates logistical advantages for medical manufacturers while adding important life sciences infrastructure to the Gulf Coast region.

As the company has grown, it has engaged with multiple organizations across Alabama’s entrepreneurial ecosystem. Gulf Sterilization was a finalist in the 2025 Alabama Launchpad Life Sciences competition and participated in the 2026 gBETA Gulf Coast accelerator presented by gener8tor and Innovation Portal. Today, the company is also part of Hatch’s biotech accelerator cohort, where it continues to strengthen its growth strategy, investment readiness and commercialization efforts.

Together, these milestones reflect the trajectory of a company growing from a local concept into a scalable business while leveraging resources from across Alabama’s innovation network.

Growing an Ecosystem, Not Just Companies

South Alabama’s growth demonstrates the value of a connected ecosystem where founders can access different resources at different stages of growth. Organizations like Hatch, Innovation Portal, Alabama Launchpad and Innovate Alabama each play distinct roles in supporting entrepreneurs, helping bridge the gap between research, commercialization, talent development and capital access.

That collaborative approach is particularly important in life sciences, where successful commercialization often requires years of research, regulatory navigation, specialized expertise and investment.

VivoSphere, Endeavor Orthopaedics and Gulf Sterilization’s growth continue to showcase exactly what is possible when innovative founders have access to the right support network.